White House Unveils Actions To Speed Precision Medicine
This article was originally published in Scrip
Executive Summary
The White House on Feb. 25 unveiled new actions and commitments from government agencies, including the National Institutes of Health (NIH) and the FDA, and private-sector participants, including Pfizer Inc. and Roche AG unit Genentech Inc., aimed at speeding President Barack Obama's Precision Medicine Initiative (PMI) forward.
You may also be interested in...
'App-A-Thon' Aims To Create PrecisionFDA Software Library To Advance Next-Gen Sequencing
US FDA is challenging stakeholders to develop apps that users of its precisionFDA platform can leverage to advance next-generation sequencing technology. Results from the competition will be announced by Commissioner Robert Califf next month in Washington, DC.
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.